331 related articles for article (PubMed ID: 31153833)
1. Postoperative adjuvant sorafenib improves survival outcomes in hepatocellular carcinoma patients with microvascular invasion after R0 liver resection: a propensity score matching analysis.
Zhang XP; Chai ZT; Gao YZ; Chen ZH; Wang K; Shi J; Guo WX; Zhou TF; Ding J; Cong WM; Xie D; Lau WY; Cheng SQ
HPB (Oxford); 2019 Dec; 21(12):1687-1696. PubMed ID: 31153833
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
[TBL] [Abstract][Full Text] [Related]
3. Postoperative Adjuvant Transarterial Chemoembolization Improves Outcomes of Hepatocellular Carcinoma Associated with Hepatic Vein Invasion: A Propensity Score Matching Analysis.
Zhang XP; Liu YC; Chen ZH; Sun JX; Wang K; Chai ZT; Shi J; Guo WX; Wu MC; Lau WY; Cheng SQ
Ann Surg Oncol; 2019 May; 26(5):1465-1473. PubMed ID: 30767178
[TBL] [Abstract][Full Text] [Related]
4. Impact of preoperative TACE on incidences of microvascular invasion and long-term post-hepatectomy survival in hepatocellular carcinoma patients: A propensity score matching analysis.
Yang Y; Lin K; Liu L; Qian Y; Yang Y; Yuan S; Zhu P; Huang J; Liu F; Gu F; Fu S; Jiang B; Liu H; Pan Z; Lau WY; Zhou W
Cancer Med; 2021 Mar; 10(6):2100-2111. PubMed ID: 33650288
[TBL] [Abstract][Full Text] [Related]
5. An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study.
Zhang XP; Wang K; Wei XB; Li LQ; Sun HC; Wen TF; Chai ZT; Chen ZH; Shi J; Guo WX; Xie D; Cong WM; Wu MC; Lau WY; Cheng SQ
Oncologist; 2019 Dec; 24(12):e1476-e1488. PubMed ID: 31138726
[TBL] [Abstract][Full Text] [Related]
6. Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: A propensity score matching analysis.
Zhao H; Chen C; Gu S; Yan X; Jia W; Mao L; Qiu Y
J Gastroenterol Hepatol; 2017 Apr; 32(4):870-878. PubMed ID: 27671209
[TBL] [Abstract][Full Text] [Related]
7. Perioperative and long-term survival outcomes of laparoscopic versus laparotomic hepatectomy for BCLC stages 0-A hepatocellular carcinoma patients associated with or without microvascular invasion: a multicenter, propensity score matching analysis.
Yang SY; Yan ML; Duan YF; Feng JK; Ye JZ; Xiang YJ; Liu ZH; Guo L; Xue J; Cheng SQ; Guo WX
Hepatol Int; 2022 Aug; 16(4):892-905. PubMed ID: 35704267
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of microvascular invasion in early-intermediate stage hepatocelluar carcinoma: a propensity score matching analysis.
Shen J; Wen J; Li C; Wen T; Yan L; Li B; Yang J; Lu C
BMC Cancer; 2018 Mar; 18(1):278. PubMed ID: 29530006
[TBL] [Abstract][Full Text] [Related]
9. Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular Carcinoma.
Peng Z; Chen S; Xiao H; Wang Y; Li J; Mei J; Chen Z; Zhou Q; Feng S; Chen M; Qian G; Peng S; Kuang M
Radiology; 2019 Jul; 292(1):237-247. PubMed ID: 31135299
[TBL] [Abstract][Full Text] [Related]
10. Overall survival in response to sorafenib with transarterial chemoembolization for BCLC stage B hepatocellular carcinoma: propensity score analysis
.
Huang Y; Chen B; Liu N; Li N; Dao H; Chen W; Yang J
Int J Clin Pharmacol Ther; 2017 Jun; 55(6):498-508. PubMed ID: 28157070
[TBL] [Abstract][Full Text] [Related]
11. Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysis.
Li C; Wang MD; Lu L; Wu H; Yu JJ; Zhang WG; Pawlik TM; Zhang YM; Zhou YH; Gu WM; Wang H; Chen TH; Han J; Xing H; Li ZL; Lau WY; Wu MC; Shen F; Yang T
Hepatol Int; 2019 Nov; 13(6):736-747. PubMed ID: 31486964
[TBL] [Abstract][Full Text] [Related]
12. Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study.
Wang L; Wang W; Rong W; Li Z; Wu F; Liu Y; Zheng Y; Zhang K; Siqin T; Liu M; Chen B; Wu J
BMC Cancer; 2020 Jul; 20(1):614. PubMed ID: 32611327
[TBL] [Abstract][Full Text] [Related]
13. Survival Benefit of Experience of Liver Resection for Advanced Recurrent Hepatocellular Carcinoma Treated with Sorafenib: A Propensity Score Matching Analysis.
Hsueh KC; Lee CC; Huang PT; Liang CY; Yang SF
Curr Oncol; 2023 Mar; 30(3):3206-3216. PubMed ID: 36975456
[TBL] [Abstract][Full Text] [Related]
14. Postoperative adjuvant transcatheter arterial chemoembolization should be considered selectively in patients who have hepatocellular carcinoma with microvascular invasion.
Wang YY; Wang LJ; Xu D; Liu M; Wang HW; Wang K; Zhu X; Xing BC
HPB (Oxford); 2019 Apr; 21(4):425-433. PubMed ID: 30249510
[TBL] [Abstract][Full Text] [Related]
15. Sorafenib after resection improves the outcome of BCLC stage C hepatocellular carcinoma.
Li J; Hou Y; Cai XB; Liu B
World J Gastroenterol; 2016 Apr; 22(15):4034-40. PubMed ID: 27099447
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant transcatheter arterial chemoembolization after radical resection of hepatocellular carcinoma patients with tumor size less than 5 cm: a retrospective study.
Lazuardi F; Valencia J; Zheng S
Scand J Gastroenterol; 2019 May; 54(5):617-622. PubMed ID: 31079496
[No Abstract] [Full Text] [Related]
17. Microvascular invasion and positive HB e antigen are associated with poorer survival after hepatectomy of early hepatocellular carcinoma: A retrospective cohort study.
Liu J; Zhu Q; Li Y; Qiao GL; Xu C; Guo DL; Tang J; Duan R
Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):330-338. PubMed ID: 29551612
[TBL] [Abstract][Full Text] [Related]
18. Sorafenib vs surgical resection for hepatocellular carcinoma with macrovascular invasion: A propensity score analysis.
Costentin CE; Decaens T; Laurent A; Nault JC; Paule B; Letoublon C; Luciani A; Calderaro J; Adam R; Bricault I; Amaddeo G; Cherqui D; Mallat A; Samuel D; Duvoux C; Ganne-Carrié N; Roudot-Thoraval F; Vibert E
Liver Int; 2017 Dec; 37(12):1869-1876. PubMed ID: 28609020
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant sorafenib after heptectomy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma patients.
Xia F; Wu LL; Lau WY; Huan HB; Wen XD; Ma KS; Li XW; Bie P
World J Gastroenterol; 2016 Jun; 22(23):5384-92. PubMed ID: 27340354
[TBL] [Abstract][Full Text] [Related]
20. Effect of transarterial chemoembolization as postoperative adjuvant therapy for intermediate-stage hepatocellular carcinoma with microvascular invasion: a multicenter cohort study.
Xiang C; Shen X; Zeng X; Zhang Y; Ma Z; Zhang G; Song X; Huang T; Yang J
Int J Surg; 2024 Jan; 110(1):315-323. PubMed ID: 37812183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
